Status:
UNKNOWN
Quantification of Chest Wall Changes After Nuss Bar Removal Utilizing Three-dimensional Optical Surface Scans
Lead Sponsor:
Zuyderland Medisch Centrum
Conditions:
Pectus Excavatum
Eligibility:
All Genders
Phase:
NA
Brief Summary
Pectus excavatum is the most common anterior chest wall deformity that affects up to 1:400 of newborns. If an operative correction is indicated, patients are often operated via the Ravitsch or Nuss ba...
Eligibility Criteria
Inclusion
- Patients that received 1 or more Nuss bar(s) to treat pectus excavatum and is/are scheduled to be removed due to the end of treatment.
Exclusion
- Patients in which the Nuss bar(s) or its stabilizers are or have been dislocated.
- Patients that received a second operation to treat any complications regarding the initial Nuss bar implantation.
- Patients with proven connective tissue diseases (e.g. Marfan's syndrome).
- Patients with a diagnosis of epilepsy (as the 3D scanner utilizes flashing light to acquire the torso topography)
- Patients that are not fit to remain in a standing position with their arms above shoulder level for a maximum of 60 seconds.
Key Trial Info
Start Date :
January 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2022
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT04052321
Start Date
January 1 2021
End Date
January 1 2022
Last Update
November 4 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zuyderland Medical Centre
Heerlen, Limburg, Netherlands, 6419PC